Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 23:10:829927.
doi: 10.3389/fped.2022.829927. eCollection 2022.

Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review

Rong Yang  1   2 , Yuan Ai  1   2 , Chuan Liu  1   3 , Xiaoxi Lu  1   2
Affiliations
Case Reports

Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review

Rong Yang et al. Front Pediatr. .

Abstract

Aggressive natural killer cell leukemia (ANKL) is a rare malignant tumor, especially uncommon in children. ANKL has very aggressive clinical course and bad prognosis and is usually caused by Epstein-Barr virus infection. ANKL often has clinical manifestations of hemophagocytic lymphohistiocytosis (HLH) and can be easily treated as HLH, which might complicate this aggressive disease. Here we report an ANKL in adolescent whose clinical presentation was highly aggressive and response to L-asparaginase containing chemotherapy was very bad. Early-onset Flow cytometry of peripheral blood and bone marrow help make the diagnosis.

Keywords: Epstein-Barr virus; aggressive natural killer cell leukemia; case report; children; hemophagocytic lymphohistiocytosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Wright-Giemsa stain of bone marrow (×1,000). (A) Hemophagocytosis in bone marrow smear. (B–D) Large granular variant lymphocytes in bone marrow smear and the proportion was 6%.
FIGURE 2
FIGURE 2
The flow cytometry detection of bone marrow revealed CD3–CD56+ cells counted for 55.67% of the lymphocytes, with HLA-DR+, CD2+, CD7 (dim)+, CD16+, CD38+, CD56+, and CD3–.
FIGURE 3
FIGURE 3
Axial magnetic resonance imaging of the brain in this ANKL patient. Axial T2-weighted (1B–3B) and fluid-attenuated inversion recovery (1C–3C) of brain showing white matter high signal at bilateral centrum ovale, periventricular areas, basal ganglia areas and pontine. Axial T1-weighted (2A) imaging and diffusion-weighted imaging (2D) shows high signal at areas of putamen and caudate nucleus head.
FIGURE 4
FIGURE 4
Typical laboratory indexes of blood and the drugs used for the patient from day of admitting, she died 55 days later. LDH, lactic dehydrogenase; ALY, atypical lymphocyte; WBC, white blood cell; DDI, D-Dimer; DEX, dexamethasone; MP, methylprednisolone; VP16, etoposide; DOX-lip, doxorubicin liposomes; L-Asp, L-asparaginase; BTZ, bortezomib.
See this image and copyright information in PMC

References

    1. Matutes E. The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms. Int J Lab Hematol. (2018) 40(Suppl 1):97–103. 10.1111/ijlh.12817 - DOI - PubMed
    1. Tang YT, Wang D, Luo H, Xiao M, Zhou HS, Liu D, et al. Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood Cancer J. (2017) 7:660. 10.1038/s41408-017-0021-z - DOI - PMC - PubMed
    1. Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. (2010) 21:1032–40. 10.1093/annonc/mdp418 - DOI - PubMed
    1. Henter JI, Aricò M, Egeler RM, Elinder G, Favara BE, Filipovich AH, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatric Oncol. (1997) 28:342–7. 10.1002/(sici)1096-911x(199705)28:53.0.co;2-h - DOI - PubMed
    1. Ishida F. Aggressive NK-Cell Leukemia. Front Pediatr. (2018) 6:292. 10.3389/fped.2018.00292 - DOI - PMC - PubMed

Publication types